Theralase Technologies Inc. (CVE:TLT)’s share price shot up 13.8% during trading on Thursday . The company traded as high as C$0.34 and last traded at C$0.33. 93,758 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 249,958 shares. The stock had previously closed at C$0.29.
ILLEGAL ACTIVITY WARNING: This news story was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.thelincolnianonline.com/2018/11/10/theralase-technologies-tlt-shares-up-13-8.html.
About Theralase Technologies (CVE:TLT)
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. It operates in two divisions, Photo Dynamic Therapy and Therapeutic Laser Technology.
Further Reading: Correction
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.